Cover Image

Source data for "Immune imprinting and vaccination interval determine antibody responses to XBB.1.5 vaccination"

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Author:	Wrynla, Xammy Huu
Format:	Recurso digital
Published:	Zenodo 2025
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

JN.1 neutralizing antibody titers after XBB.1.5 monovalent vaccine boost in healthcare workers and people with HIV
by: Giulia Matusali, et al.
Published: (2024)

Neutralizing antibody response to SARS‐CoV‐2 bivalent mRNA vaccine in SIV‐infected rhesus macaques: Enhanced immunity to XBB subvariants by two‐dose vaccination
by: Julia N. Faraone, et al.
Published: (2024)

XBB.1.16‐RBD‐based trimeric protein vaccine can effectively inhibit XBB.1.16‐included XBB subvariant infection
by: Dandan Peng, et al.
Published: (2024)

Religious engagement and antibody response to the COVID‐19 vaccine
by: Grace McMahon, et al.
Published: (2024)

Immune profiling of responses to influenza vaccination in patients with myeloproliferative neoplasms
by: Petra Bachanová, et al.
Published: (2024)

Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5‐ and BA.5‐XBB‐convalescent subpopulations
by: Xiaoyun Yang, et al.
Published: (2024)

Intramuscular EHV vaccination results in systemic and mucosal antibodies
Published: (2024)

Immune interface interference vaccines: An evolution‐informed approach to anti‐bacterial vaccine design
by: Nicholas J. Croucher
Published: (2024)

Neutralizing antibody response after immunization with a COVID‐19 bivalent vaccine: Insights to the future
by: Milena Silva Souza, et al.
Published: (2024)

Prophylactic antibodies inhibit spike‐specific T and B cell responses after COVID‐19 vaccination
by: Henrik E. Mei, et al.
Published: (2024)

Neutralizing antibody levels and cellular immune response against Omicron variant in pregnant women vaccinated with mRNA and inactivated SARS‐CoV‐2 vaccines
by: E. Kalafat, et al.
Published: (2024)

PLGA‐particle‐based vaccine induces SARS‐CoV‐2‐specific antibody and T‐cell responses
by: Dennis Horvath, et al.
Published: (2026)

Immune responses to mRNA‐based vaccines given as a third COVID‐19 vaccine dose in people living with HIV—a literature review
by: Maria Lodberg Knudsen, et al.
Published: (2024)

New variants of COVID‐19 (XBB.1.5 and XBB.1.16, the “Arcturus”): A review of highly questioned concerns, a brief comparison between different peaks in the COVID‐19 pandemic, with a focused systematic review on expert recommendations for prevention, vaccination, and treatment measures in the general population and at‐risk groups
by: Homa Pourriyahi, et al.
Published: (2024)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
by: Deborah L Burnett, et al.
Published: (2026)

The effect of stress on the antibody response after vaccination in children aged 0–18 years: A systematic review
by: Rikke Svensson, et al.
Published: (2024)

Effectiveness of XBB.1.5 Monovalent COVID‐19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS‐EHR Network Study
by: Susana Monge, et al.
Published: (2024)

Mathematical modelling to inform outbreak response vaccination
by: Shankar, Manjari, et al.
Published: (2024)

Evaluation of the immune response of layer chickens to Newcastle disease virus vaccines using the new vaccination regimens
by: Abel Sorsa Geletu, et al.
Published: (2024)

Omicron breakthrough infections after triple‐dose inactivated COVID‐19 vaccination: A comprehensive analysis of antibody and T‐cell responses
by: Tiandan Xiang, et al.
Published: (2024)

Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination
by: Nicole L Messina, et al.
Published: (2025)

Seropositivity against vaccine preventable infections in the early post chimeric antigen receptor T‐cell period: Preservation of vaccine‐associated antibodies between 0 and 6 months
by: Gemma K. Reynolds, et al.
Published: (2024)

Natural direct effects of vaccines and post-vaccination behaviour
by: Gonçalves, Bronner P., et al.
Published: (2026)

Realising the promise of HPV vaccination – data from the national cervical screening and vaccination registers demonstrates the impact of HPV vaccination in Aotearoa New Zealand
by: Peter Sykes, et al.
Published: (2025)

Immune response and protection efficacy of formalin‐killed vaccines against Streptococcus iniae in four‐finger threadfin Eleutheronema tetradactylum
by: Yin‐Ze Shi, et al.
Published: (2024)

Role of serum antibodies in protection of vaccinated turbot (Scophthalmus maximus) against vibriosis / J. Estévez
by: Estévez, J
Published: (1994)

IL‐2 silencing enables Tfh cell expansion during vaccination but is redundant for antibody production
by: Silvia Innocentin, et al.
Published: (2026)

Boosting vaccination: Accelerating vaccine uptake through communication science
by: Victoria Ledford
Published: (2023)

Expression of immuno‐transcriptome response in red hybrid tilapia (Oreochromis sp.) hindgut following vaccination with feed‐based bivalent vaccine
by: Nur Shidaa Mohd Ali, et al.
Published: (2024)

Persistence of antibodies 5 years after hepatitis B vaccination in preterm birth children: A retrospective cohort study using real‐world data
by: Wei Qin, et al.
Published: (2024)

A study on determining the views of people on the COVID-19 vaccine
by: Tengilimoğlu, Dilaver, et al.
Published: (2025)

Rabies virus vaccines: Is there a need for a pan-lyssavirus vaccine?
by: Evans, Jennifer S., et al.
Published: (2012)

Robust evaluation of vaccine effects based on estimation of vaccine efficacy curve
by: Zhao, Ziwei, et al.
Published: (2024)

Monitoring and evaluation of vaccination coverage of the yellow fever vaccine: integrative review
by: Cosme Rezende Laurindo
Published: (2024)

COVID-19 vaccines: Development, strategies, types and vaccine usage hesitancy
by: Ayisha Shaukat
Published: (2021)

Unveiling the responsible antigen in vaccine‐induced immune thrombotic thrombocytopenia
by: Chika Edward Uzoigwe
Published: (2025)

Modeling the response of an endangered rabbit population to RHDV2 and vaccination
by: Robin E. Russell, et al.
Published: (2024)

Loss of seroprotective antibody after a full series of hepatitis A virus vaccination in people with HIV
by: Chien‐Ching Hung
Published: (2024)

The association between HLA-B40, HLA-DQA1*01 and HLA-DQB1*05 alleles and antibody response to hepatitis B vaccination in turkish hemodialysis patients
by: Gürsel Ersan
Published: (2019)

Cutaneous reactions to vaccination
by: Jacqueline Kussini, et al.
Published: (2025)